Advanstar reports first-half revenues up 13%

Share this article:
Advanstar reported first-half revenues up 13% year-on-year, from $146 million to $165 million--though its life sciences division was nearly flat for Q2. Revenues from Advanstar life sciences properties rose by 3% for the period, as overall revenues rose 6%, largely on a 24% jump in the firm's power sports division. 
Share this article:
close

Next Article in News

Email Newsletters

More in News

BI rethinks hepatitis business, posts 2013 results

BI rethinks hepatitis business, posts 2013 results

Boehringer Ingelheim says it is no longer pursuing an interferon-free combination of faldaprevir and deleobuvir.

Roche wraps quarter with two fewer pipeline medications

Roche wraps quarter with two fewer pipeline medications

Roche also announced first-quarter sales shrank 1%.

2013 favored specialists, specialty Rx

2013 favored specialists, specialty Rx

The latest IMS Institute for Healthcare Informatics assessment of 2013's prescription drug use shows that 2.3% of prescriptions account for 30% of a patient's out-of-pocket prescription costs.